| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Expenses | ||||||
Research and development | ||||||
54,726 | 32,513 | |||||
General and administrative | ||||||
17,845 | 7,060 | |||||
Total expenses | ||||||
72,571 | 39,573 | |||||
Interest and other income (expense) | ||||||
Other income | ||||||
2,134 | 961 | |||||
Interest income | ||||||
3,213 | 714 | |||||
Interest expense | ||||||
6 | 9 | |||||
Preferred stock warrant liability revaluation | ||||||
123 | 33 | |||||
Foreign exchange loss | ||||||
-8 | - | |||||
Loss on disposal of property and equipment | ||||||
-122 | -1 | |||||
Loss before income tax expense | ||||||
-67,483 | -37,941 | |||||
Income tax expense | ||||||
1 | -1 | |||||
Net loss | ||||||
-67,484 | -37,940 | |||||
Net loss per share, basic and diluted | ||||||
-4.26 | -18.02 | |||||
Weighted-average shares used in computing net loss per share, basic and diluted | ||||||
15,834 | 2,104 | |||||